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CARDIOMETABOLIC HEALTH
A.M. Coates 1, J.A. Barbour 1, J.D. Buckley 1, J. Bryan 2, P.R.C.
Howe1,3. 1Nutritional Physiology Research Centre Social Work and Social
Policy, University of South Australia, Australia; 2Department of Psychology,
Social Work and Social Policy, University of South Australia, Australia;
3Clinical Nutrition Research Centre, University of Newcastle, Australia
E-mail: alison.coates@unisa.edu.au (A.M. Coates)
Background/Aims: Epidemiological evidence indicates an inverse associ-
ation between nut consumption and obesity, inﬂammation, hyper-
lipidaemia and glucose intolerance. We sought to investigate whether
daily consumption of hi-oleic peanuts compared with a nut free diet
improved adiposity and cardio-metabolic risk markers.
Methods: Sixty one healthy participants (mean ± SD age 65 ± 1 years, BMI
31 ± 1 kg/m2) consumed hi-oleic peanuts (56 g/day for 32 women; 84 g/d
for 29 men) or a nut free diet for 12 weeks, in a randomised cross-over
design. Body mass, body composition (measured by dual emission x-ray
absorptiometry), C-reactive protein (CRP), lipids, glucose and insulin were
assessed at baseline and at the end of each 12-week period. Repeated
measures analysis controlling for baseline was used to compare the two
diets.
Results: Energy intake was 9 % higher (780 kJ, p < 0.05), with no difference
in energy expenditure following the peanut phase compared with the
control diet. This was attributed to a 23% (22 g) increase in fat intake (p <
0.001), predominantly monounsaturated (20 g, p < 0.05). Despite the
greater energy and monounsaturated fat intakes during the peanut phase
compared with the nut free diet, there were no differences in body weight,
body composition and other cardio-metabolic risk markers (lipids, CRP,
glucose and insulin).
Conclusions: Consumption of hi-oleic peanuts did not alter cardio-meta-
bolic biomarkers or body composition despite the additional energy and
monounsaturated fat intake. It is possible that incomplete nutrient ab-
sorption occurred, resulting in reduced energy utilisation from the peanuts.
Funding source(s): ARC, Peanut Company of Australia.
BIOFORTIFIED PRODUCE e QUEEN GARNET, A NEW HIGH ANTHOCYAN
PLUM
M. Netzel 1, A. Bobrich 2, B. Topp 1, D. Russel 2, G. Netzel 1, B. Flanagan 1, M.J.
Gidley 1, K.J. Fanning 2. 1Queensland Alliance for Agriculture & Food
Innovation, The University of Queensland, St. Lucia QLD, Australia; 2Agri-
Science Queensland, Department of Agriculture, Fisheries and Forestry,
Coopers Plains QLD, Australia
E-mail: m.netzel@uq.edu.au (M. Netzel)
Background/Aims: Recent publications indicate that the consumption of
dietary anthocyanins from fresh food, juice or puree may exert protection
against cardiovascular risk factors and type 2 diabetes. The aim of this
study was to investigate the bioavailability and metabolism of anthocya-
nins from Queen Garnet plum (QGP), a new, high anthocyanin plum.
Methods: In vitro: blended QGP was subjected to simulated gastric and
small intestinal digestion and the bioaccessible anthocyanins were ana-
lysed by HPLC-photodiode array detection (PDA)-MS. In vivo: Ten healthy
men (18-35 years; mean ± SD BMI: 22.9 ± 3.2 kg/m2) consumed 400 mL
QGP juice (QGPJ; 0.95 mmol total anthocyanins and 8.6 mmol total poly-
phenols) or water (control) in a randomised cross-over design. Urinary
excretion of intact anthocyanins and metabolites was analysed up to 24 h
post-intake by HPLC-PDA-MS and NMR spectroscopy. Differences between
treatments were tested using one-way ANOVA.
Results: The amount of bioaccessible cyanidin-3-glucoside and cyanidin-
3-rutinoside from QGP was relatively high (59%) whereas the urinary
excretion, mainly as methylated, glucuronidated and sulphated metabo-
lites, was low (0.2% of the ingested dose). Urinary hippuric acid, a colonic/
hepatic polyphenol/anthocyanin “end-metabolite”, was increased 4.5-fold
(p < 0.05) after QGPJ consumption (4.35 vs. 0.97 mmol/24 h). Malondial-
dehyde was signiﬁcantly reduced (p < 0.05) after QGPJ consumption.
Conclusions: It is suggested that QGP anthocyanins are (1) readily bio-
accessible, which may be due to the high content in the ﬂesh, and (2)
subjected to an intensive metabolism in vivo which may alter theirbioactivity and subsequently “dietary value”. Follow-up studies are in
progress to investigate this further.
Funding source(s): HAL and Nutrafruit Pty Ltd.Concurrent session 6: micronutrients and
biomarkers
METALLOTHIONEIN (MT-2A) GENE EXPRESSION IS UPREGULATED
AFTER ZINC SUPPLEMENTATION IN HEALTHY INDIVIDUALS
A. Chu 1, S. Ward 1, K. Zaman 1, M. Foster 1, P. Petcoz 2, S.
Samman 1. 1Discipline of Nutrition & Metabolism, School of Molecular
Bioscience, University of Sydney, Australia; 2Department of Statistics,
Macquarie University, Australia
E-mail: achu7215@uni.sydney.edu.au (A. Chu)
Background/Aims: In in vitro studies, zinc has been shown to affect the
gene expression of zinc transporters and metallothioneins (MT), which are
responsible for regulating cellular zinc homeostasis. Expression of these
genes may provide novel biomarkers of zinc status in humans.
Methods: Healthy adults (n ¼ 39) were randomised to a zinc supplement
group (20 mg elemental Zn/day; n ¼ 19) or no treatment (n ¼ 20) for 21
days. Blood samples were collected on days 0, 2, 7, 14 and 21. Plasma zinc
concentrations were analysed using Atomic Absorption Spectrometry. RNA
was extracted from peripheral blood mononuclear cells and mRNA
expression of zinc transporters, MT-1A and MT-2A were analysed using
real-time PCR. Repeated-measures ANOVA were used to test differences
between groups.
Results: Thirty-ﬁveparticipants completed the trial (zinc,n¼ 17; control,n¼
18). In the zinc group, plasma zinc concentrations increased frombaseline by
0.98 ± 0.67 mmol/L (mean ± SEM) on day 21 (p ¼ 0.316). MT-2A expressions
were signiﬁcantly different between groups (p < 0.05) with a signiﬁcant
increaseonday2 in the zinc group (35±17%,p<0.05).No signiﬁcant changes
were observed in other measured gene expression of zinc transporters.
Within-subject coefﬁcients of variation in gene expression of zinc trans-
porters and MT ranged from 19-35% (n ¼ 18). Gene expressions of zinc
transporters andMTwere not related to plasma zinc or habitual dietary zinc.
Conclusions: This pilot study showed up-regulation of MT gene expres-
sion following zinc supplementation and may be reﬂective of increased
dietary zinc intake over the preceding days.
Funding source(s): University of Sydney andMeat and Livestock Australia.
LONG TERM FOLLOW-UP OF DETERMINANTS OF SEASONAL VARIATION
IN VITAMIN D STATUS IN OLDER ADULTS
J. Pittaway 1, K.D.K. Ahuja 1, J. Beckett 1, M.L. Bird 1, I. Robertson 1, M.
Ball 1. 1 School of Health Sciences, University of Tasmania, Launceston, TAS,
Australia
E-mail: Jane.Pittaway@utas.edu.au (J. Pittaway)
Background/Aims: To investigate behavioural impact on long-term sea-
sonal vitamin D (vitD) status in older Tasmanian adults.
Methods: Seventy participants in a study investigating determinants of
vitD status returned for follow-up assessment nine months (winter) and
26 months (summer) after study completion (21 male, 49 female; mean ±
SD age 69.2 ± 6.4 years, range 60-84 years). Changes in diet, supplement
use, time spent outside, sun protection and serum vitD concentrationwere
compared between four time points (summer and winter during the study,
winter and summer follow-up) using repeated measures mixed effects
linear regression.
Results:Mean±SD serumvitD (nmol/L) in summerduring-study (68.8±22.1)
was signiﬁcantlyhigher (p<0.001) thanwinterduring-study (52.6±20.9) and
signiﬁcantly lower (p < 0.001) than summer follow-up (78.5 ± 16.7) but not
different to winter follow-up (65.8 ± 18.3). Winter during-study was signiﬁ-
cantly lower (p < 0.001) than all other time-points. During the study, 15/70
participants took vitD supplements. At nine and 26 months it was 38/70 and
42/70. There was a signiﬁcant difference in vitD status between supplement
and non-supplement groups during-study and winter follow-up (p < 0.04);
however, summer follow-up results were not different between the two
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icant increase in intake of cheese and dairy-based foods (e.g. fromage frais and
custards) but time spent outside reduced signiﬁcantly (both p < 0.001). Sun
protection behaviours differed between summer and winter only (p < 0.001).
Conclusions: The major behavioural change responsible for increased vitD
status post-study was the increase in supplement use.
Funding source(s): Clifford Craig Medical Research Trust.
LOW CALCIUM INTAKE IS RELATED TO CORTICAL POROSITY IN WOMEN
OVER 80 YEARS OF AGE
S. Iuliano 1, R. Zebaze 1, A. Ghasem-Zadeh 1, E. Seeman 1. 1Department of
Endocrinology, University of Melbourne / Austin Health, Heidelberg, Australia
E-mail: sandraib@unimelb.edu.au (S. Iuliano)
Background/Aims: About 85-90% of the skeleton in over 80 year-olds is
cortical because most trabecular bone has been resorbed. High remodel-
ling is exacerbated by secondary hyperparathyroidism likely contributed
to by low calcium intakes. We hypothesized that cortical porosity will be
high in older women and more severe in those with elevated parathyroid
hormone (PTH) and low calcium intakes.
Methods: We imaged distal tibial microstructure in 36 elderly women
(mean ± SD age 89 ± 4 years) and 73 post-menopausal women (age 60 ± 5
years) using high-resolution peripheral quantitative computed tomogra-
phy (HR-pQCT) and quantiﬁed porosity using StrAx1.0. We used t-tests for
group comparisons, and regressions to determine variable relationships.
Results: Despite similar bone area, in older compared with younger
women respectively, cortical area was ~12% smaller (101 ± 24 vs. 114 ± 17
mm2), ~21% less dense (586 ± 90 vs. 745 ± 75 mgHA/cc) and porosity ~25%
higher (60.9 ± 8.7 vs. 45.4 ± 7.4%) (all p < 0.01). In older women, PTH was
elevated (9.0 ± 4.4 vs 4.5 ± 1.8 pmol/L, p < 0.001) and dietary calcium
intake low (636 ± 175 mg/day) with 2/3 consuming <600 mg/day. PTH
levels in the elderly women were systemically elevated, and the small
sample size may have limited the ability to detect a relationship with
porosity. Dietary calcium in the elderly was related to porosity in those
with intakes below 600 mg/day (r ¼ 0.47, p ¼ 0.05).
Conclusions: We infer that a reduced calcium intake independently con-
tributes to deﬁcits in cortical bone by inﬂuencing intracortical remodel-
ling. Studies are needed to examine the effects of calcium intakes below
600 mg/day on bone loss and the effects of repletion in the elderly.
Funding source(s): Six dairy organisations from the US, Europe and
Australia.
PLASMA IRISIN LEVELS ARE INVERSELY RELATED TO INSULIN AND
HOMA-IR IN HEALTHY SUBJECTS
F. Jameel 1,2, B. Plunkett 1,2, L.G. Wood 2, M.L. Garg 1,2. 1Nutraceuticals
Research Group, University of Newcastle, Australia; 2 School of Biomedical
Sciences & Pharmacy, University of Newcastle, Australia
E-mail: Faizan.Jameel@newcastle.edu.au (F. Jameel)
Background/Aims: Irisin, a myokine encoded by ﬁbronectin type III
domain containing 5 (FNDC5) gene, expressed and produced by human
muscle and adipose tissue, has been reported to stimulate conversion of
white adipose tissue to brown adipose tissue and increase the expression
of uncoupling protein 1. Health beneﬁcial effects of exercise are thought to
be mediated via increased production of irisin. This study aimed to assess
the association between plasma irisin levels and anthropometric mea-
surements and glycaemic indices in healthy adults.
Methods: Forty nine free living healthy male and female adults were
recruited. Body weight, height, and body composition measurements
were taken. Fasting blood samples were collected for the analysis of
glucose, insulin and irisin levels. Insulin resistance score, HOMA-IR, was
calculated using fasting blood glucose and insulin values. The relationship
between plasma irisin level and anthropometric measurements, glucose,
insulin and HOMA-IR was determined using Pearson’s bivariate correla-
tion test.
Results: A signiﬁcant inverse relationship was found between plasma
irisin levels and insulin (r¼ -0.380; p ¼ 0.007) and HOMA-IR (r ¼ -0.362; p
¼ 0.011). No signiﬁcant relationship was apparent between irisin and
blood glucose level, BMI, waist/hip ratio, muscle mass or fat mass.Conclusions: This study reports an inverse relationship between plasma
irisin levels versus fasting insulin levels and HOMA-IR in healthy subjects in
support of a link between circulating levels of irisin and insulin resistance.
Funding source(s): Hunter Medical Research Institute.
ZINC INTAKE IN OBESE ADOLESCENTS AT RISK OF TYPE 2 DIABETES ON
LOW-ENERGY DIETS
M. Ho 1,2, A.L. Heath 3, L.A. Baur 1,4, C.T. Cowell 1,2,4, S. Samman 3, S.P.
Garnett 1,2,4. 1 The Children's Hospital at Westmead Clinical School,
University of Sydney, Australia; 2 Institute of Endocrinology and Diabetes,
The Children's Hospital at Westmead, Australia; 3Department of Human
Nutrition, University of Otago, New Zealand; 4Kids Research Institute, The
Children’s Hospital at Westmead, Australia
E-mail: sarah.garnett@health.nsw.gov.au (S.P. Garnett)
Background/Aims: Zinc has a critical role in metabolism, growth and
development. In adults, impaired zinc metabolism is associated with heart
disease and T2DM.This study aimed to assess zinc intake, zinc bioavail-
ability (phytate:zinc molar ratio) and the prevalence of inadequate zinc
intake in obese adolescents consuming low-energy diets differing in
macronutrient composition.
Methods: Participants were 96 obese adolescents (ages 10 to 17 years; 54
girls; mean ± SD BMI z-score 2.2 ± 0.37) with prediabetes and/or clinical
insulin resistance. Adolescents were randomised to a low-energy diet (6.0
to 8.0 MJ), which was either high carbohydrate or moderate carbohydrate
with increased protein. Zinc and phytate intakes were estimated from
three 24-hour dietary recalls at 6, 9 and 12 weeks after randomisation.
Results: Boys reported a higher absolute and energy-adjusted zinc intake
than girls, median 11.0 vs. 8.1 mg, p < 0.001, and 1.6 vs. 1.4 mg/MJ, p ¼
0.025, respectively. Zinc intake did not differ between the two diet groups
(p ¼ 0.523). However, adolescents in the high-carbohydrate group had a
higher median phytate intake than adolescents in the increased-protein
group (894 vs. 671 mg, p ¼ 0.009). The prevalence of low zinc bioavail-
ability (phytate:zinc ratio > 18) was 18% vs. 6%, p ¼ 0.113 and the preva-
lence of inadequate absorbable zinc intake, 22% vs. 13%, p ¼ 0.275.
Conclusions: Obese adolescents consuming low-energy diets are at risk of
inadequate absorbable zinc intake. Future studies should collect serum
zinc concentration data to conﬁrm the zinc status in this high risk group.
Funding source(s): Meat & Livestock Australia; Bupa Foundation Pty
Limited; Diabetes Australia Research Trust; NHF.
CUT-OFF POINTS FOR ASSOCIATIONS BETWEEN VITAMIN D AND
MUSCULOSKELETAL OUTCOMES VARY IN WOMEN AGED 36e57 YEARS
F. Wu 1, K. Wills 1, L. Laslett 1, B. Oldenburg 2, M. Seibel 3, G. Jones 1, T.
Winzenberg 1. 1Menzies Research Institute Tasmania, University of
Tasmania, Hobart, TAS, Australia; 2 School of Public Health and Preventive
Medicine, Monash University, Australia; 3Bone Research Program, ANZAC
Research Institute, The University of Sydney, Australia
E-mail: Feitong.Wu@utas.edu.au (F. Wu)
Background/Aims: To describe associations between serum 25-hydrox-
yvitamin D [25(OH)D] and musculoskeletal outcomes in middle-aged
women.
Methods: This cross-sectional analysis from a cohort of 348 women (mean
age 50 year) used nonlinear least-squares estimation to determine ﬂexion
points for associations of 25(OH)D with lumbar spine (LS) bone mineral
density (BMD), femoral neck (FN) BMD, lower limb muscle strength (LMS),
timed up and go test (TUG), functional reach test (FRT), lateral reach test
(LRT) and step test (ST) and piecewise regression to determine how as-
sociations differed by 25(OH)D level.
Results: Mean (95%CI) ﬂexion points were 25 (16, 33), 42 (16, 68), 26 (20,
32), 41 (23, 60), 18 (12, 24), 48 (-158, 254) and 24 (12, 35) nmol/L for FN
BMD, LS BMD, TUG, ST, FRT, LRT and LMS, respectively. Signiﬁcant associ-
ations between 25(OH)D and musculoskeletal outcomes occurred only in
participants with low 25(OH)D. Differences in slope between 25(OH)D
groups became statistically signiﬁcant at 35 nmol/L for FN BMD, blow (in
low group)¼ 0.0044 (95%CI: 0.0009, 0.0078), between-group difference in
b (Db) ¼ 0.0044, p ¼ 0.020; and TUG, blow¼-0.027 (-0.052, -0.002); Db ¼
-0.030, p¼ 0.028; 30 nmol/L for LS BMD, blow¼ 0.0059 (0.0002, 0.0117); Db
